How to cite item

Commentary: 2-year follow up of pembrolizumab as second-line therapy for advanced urothelial cancer (“KEYNOTE 045”)

   
@article{TAU29875,
	author = {Mayer Fishman},
	title = {Commentary: 2-year follow up of pembrolizumab as second-line therapy for advanced urothelial cancer (“KEYNOTE 045”)},
	journal = {Translational Andrology and Urology},
	volume = {8},
	number = {5},
	year = {2019},
	keywords = {},
	abstract = {The publication in 2017 of the KEYNOTE 045 prospective randomized phase 3 trial comparing pembrolizumab anti PD1 antibody with conventional cytotoxic chemotherapy in treatment of recurrent urothelial cancer (1) marked a watershed for immune treatment to displace conventional cytotoxic medications.},
	issn = {2223-4691},	url = {https://tau.amegroups.org/article/view/29875}
}